by Guy Page
There are no reported cases of adverse effects from the use of ivermectin to prevent and treat Covid-19, Health Dept. Commissioner Mark Levine stated during today’s press conference.
Chris Roy of the Newport Daily Express asked how much Ivermectin is used in Vermont as a Covid-19 preventive/treatment, and if any adverse experiences have been reported.
Levine answered, “It’s received a lot of press lately. The Medical and scientific press are pretty unified that it doesn’t have a role in treating human beings and preventing Covid from occurring.” Levine made repeated references to Ivermectin’s use as a veterinary medicine. He did not mention that researchers won a Nobel Prize in 2015 for establishing ivermectin’s use in treating humans for parasites, or that ivermectin is a CDC-required treatment for human refugees coming to the United States.
Science Direct also reports that “Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments.”
Levine did confirm, however, that no adverse effects from Ivermectin have been reported in Vermont. “The experience in VT – I am not aware that anyone has been treated for adverse effects. That doesn’t mean it hasn’t happened. I’m just not aware of it.”
By contrast, the Vaccine Adverse Event Reporting System (VAERS) reports 11 Vermont deaths and 68 serious adverse events from Covid-19 vaccinations through July 9. While anecdotal and not conclusive, most VAERS reports are prepared by health care providers on behalf of their patients.
Ivermectin is available by prescription in Vermont pharmacies.